Olstein Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-48,235
| Closed | -$5.28M | – | 114 |
|
|
2017
Q4 | $5.28M | Sell |
48,235
-11,877
| -20% | -$1.3M | 0.67% | 65 |
|
|
2017
Q3 | $6.49M | Sell |
60,112
-17,023
| -22% | -$1.84M | 0.84% | 49 |
|
|
2017
Q2 | $7.8M | Sell |
77,135
-30,920
| -29% | -$3.13M | 0.99% | 40 |
|
|
2017
Q1 | $9.72M | Sell |
108,055
-27,980
| -21% | -$2.52M | 1.24% | 27 |
|
|
2016
Q4 | $10.4M | Buy |
136,035
+50,410
| +59% | +$3.84M | 1.34% | 24 |
|
|
2016
Q3 | $7.14M | Buy |
85,625
+29,724
| +53% | +$2.48M | 0.94% | 48 |
|
|
2016
Q2 | $4.61M | Buy |
55,901
+31,615
| +130% | +$2.61M | 0.62% | 78 |
|
|
2016
Q1 | $1.84M | Buy |
+24,286
| New | +$1.84M | 0.25% | 97 |
|
|
2015
Q1 | – | Sell |
-32,000
| Closed | -$2.04M | – | 119 |
|
|
2014
Q4 | $2.04M | Sell |
32,000
-89,000
| -74% | -$5.66M | 0.25% | 111 |
|
|
2014
Q3 | $7.23M | Sell |
121,000
-12,000
| -9% | -$717K | 0.94% | 50 |
|
|
2014
Q2 | $7.12M | Buy |
133,000
+52,000
| +64% | +$2.78M | 0.96% | 46 |
|
|
2014
Q1 | $4.89M | Sell |
81,000
-88,000
| -52% | -$5.31M | 0.67% | 78 |
|
|
2013
Q4 | $8.96M | Sell |
169,000
-7,000
| -4% | -$371K | 1.28% | 16 |
|
|
2013
Q3 | $8.14M | Hold |
176,000
| – | – | 1.25% | 16 |
|
|
2013
Q2 | $7.22M | Buy |
+176,000
| New | +$7.22M | 1.16% | 27 |
|